跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAPRYSTA 10 MG/ML JARABE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LAPRYSTA 10 MG/ML JARABE EFG
Approved
STANDARD
LAPRYSTA 10 MG/ML JARABE EFG
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 19, 2022
Approval ID
e9be5e75ba5c5b3a
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
e9be5e75ba5c5b3a
Drug Cima Aemps Name
LAPRYSTA 10 MG/ML JARABE EFG
Register Number
87322
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2022-05-19
Dosage Form
JARABE
Dose
10 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
LACOSAMIDA
10 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 19, 2022
Approval ID
e9be5e75ba5c5b3a
Type
Standard
Back to CIMA-AEMPS Approvals